Corporate News Report
Island Pharmaceuticals Ltd. (ILA.AX) closed the trading session of Tuesday, 20 October 2026, at AUD 0.33, reflecting a decline of 2.9 % against the close at 11:40 PM Central Europe. The share price remains below the simple moving average of the last 200 days, which sits at AUD 0.40, and is 18 cent below the 52‑week low of AUD 0.31 recorded on 14 May 2026. By contrast, the 52‑week high of AUD 0.63, logged on 24 November 2025, is 30 cent above the current level.
The company’s market capitalisation stands at AUD 102.2 million, with a total outstanding supply of 300.4 million shares. During the past 24 hours, the volume traded was modest, totalling approximately AUD 23.8 k. Since the close of the previous month, Island’s share price has fallen by 20.24 %.
Performance of Related Shares
| Stock | 24‑hour Change | Current Price | Market Capitalisation | P/E Ratio |
|---|---|---|---|---|
| Rand Mining (RND.AX) | Flat (0 %) | AUD 2.12 | AUD 121.7 million | 8.77 |
| Caravel Minerals (CVV.AX) | +4.65 % | AUD 0.20 | AUD 120.1 million | — |
| Nobleoak Life (NOL.AX) | +1.92 % | AUD 1.35 | AUD 121.4 million | 8.67 |
| Cauldron Energy (CXU.AX) | Flat (0 %) | AUD 0.06 | AUD 118.1 million | — |
| Resource Minerals International (RMI.AX) | –3.85 % | AUD 0.10 | AUD 122.2 million | — |
Company Overview
Island Pharmaceuticals Ltd. is headquartered in Camberwell, Australia, and specialises in the research and repurposing of drugs aimed at preventing or treating viral infections. The company operates globally and is listed on the ASX All Markets. Further details on its research programmes and product pipeline can be found on the corporate website at www.islandpharmaceuticals.com .
This report summarises the latest trading activity and market context for Island Pharmaceuticals Ltd. and its peer group, offering a concise snapshot for investors and stakeholders monitoring performance in the Australian equity market.
